Cargando…
The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms
Over the past decade, multiple sclerosis (MS), a chronic neuroinflammatory disease with severe personal and social consequences, has undergone a steady increase in incidence and prevalence rates worldwide. Despite ongoing research and the development of several novel therapies, MS pathology remains...
Autores principales: | Schreiner, Thomas Gabriel, Romanescu, Constantin, Popescu, Bogdan Ovidiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025898/ https://www.ncbi.nlm.nih.gov/pubmed/35454127 http://dx.doi.org/10.3390/biom12040538 |
Ejemplares similares
-
In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
The Role of Human Herpesvirus 6 Infection in Alzheimer’s Disease Pathogenicity—A Theoretical Mosaic
por: Romanescu, Constantin, et al.
Publicado: (2022) -
Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022) -
Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2021) -
The “Cerebrospinal Fluid Sink Therapeutic Strategy” in Alzheimer’s Disease—From Theory to Design of Applied Systems
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)